Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Medical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12032-008-9120-9PMID 19003546
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost-Effective Real-Time Reverse Transcriptase PCR (RT-PCR) To Screen for Dengue Virus followed by Rapid Single-Tube Multiplex RT-PCR for Serotyping of the Virus

  2007cited by this paper
• Quantification of mRNA using real-time RT-PCR

  2006cited by this paper
• Overexpression of Pim-1 during progression of prostatic adenocarcinoma

  2006cited by this paper
• Study of housekeeping gene expression in human keratinocytes using OLISA, a long-oligonucleotide microarray and q RT-PCR.

  2006cited by this paper
• Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing

  2006cited by this paper
• PSA updated: still relevant in the new millennium?

  2005cited by this paper
• Expression of PIM-1 in human prostate cancer

  2005cited by this paper
• The serine/threonine kinase Pim-1.

  2005cited by this paper
• Human tissue kallikrein gene family: applications in cancer.

  2005cited by this paper
• Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA)

  2004cited by this paper
• Development of sensitive immunoassays for free and total human glandular kallikrein 2.

  2004cited by this paper
• Prognostic Value of Combined “Triple”-Reverse Transcription-PCR Analysis for Prostate-Specific Antigen, Human Kallikrein 2, and Prostate-Specific Membrane Antigen mRNA in Peripheral Blood and Lymph Nodes of Prostate Cancer Patients

  2004cited by this paper
• [Prostate cancer and prostate specific antigen screening].

  2004cited by this paper
• Applicability of biomarkers in the early diagnosis of prostate cancer

  2004cited by this paper
• Characterizing prostatic adenocarcinomas in men with a serum prostate specific antigen level of <4.0 ng/mL

  2004cited by this paper
• [Serum markers for early detection and staging of prostate cancer. Status report on current and future markers].

  2003cited by this paper
• Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.

  2003cited by this paper
• Reliability of PSA testing remains unclear

  2003cited by this paper
• Serummarker in der Früherkennung und dem Staging des Prostatakarzinoms

  2003cited by this paper
• Prostate specific antigen: an updated review.

  2003cited by this paper
• Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.

  2002cited by this paper
• Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.

  2002cited by this paper
• Expanded Human Tissue Kallikrein Family – A Novel Panel of Cancer Biomarkers

  2002cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis.

  2001cited by this paper
• Genetics of prostate cancer: too many loci, too few genes.

  2000cited by this paper
• Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.

  2000cited by this paper
• Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.

  2000cited by this paper
• Nucleic acid techniques in bacterial systematics

  1991cited by this paper
• Development and application of nucleic acid probes

  1991cited by this paper

• The multifaceted roles and diagnostic-therapeutic potential of LINC01410 in malignant tumors and non-malignant disorders

  2025cites this paper
• A review on structure-function mechanism and signaling pathway of serine/threonine protein PIM kinases as a therapeutic target.

  2024cites this paper
• Aiding Cancer’s “Sweet Tooth”: Role of Hexokinases in Metabolic Reprogramming

  2023cites this paper
• OTT_A_297969 3225..3238

  2021cites this paper
• Long Noncoding RNA LINC01410 Suppresses Tumorigenesis and Enhances Radiosensitivity in Neuroblastoma Cells Through Regulating miR-545-3p/HK2 Axis

  2021cites this paper
• PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer

  2020cites this paper
• Long noncoding RNA XIST suppresses tumorigenesis and enhances radiosensitivity in neuroblastoma cells through regulating miR-653-5p/HK2 axis

  2020cites this paper
• miR-1433 p functions as a tumor suppressor by targeting HK 2 in neuroblastomas

  2019cites this paper
• Androgen deprivation therapy has no effect on Pim-1 expression in a mouse model of prostate cancer.

  2017cites this paper
• Lectin PCL inhibits the Warburg effect of PC3 cells by combining with EGFR and inhibiting HK2.

  2017cites this paper
• miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer

  2017cites this paper
• Expression of HK2 Gene is Deregulated in Prostate Cancer

  2017cites this paper
• Evolution of equine infectious anaemia in naturally infected mules with different serological reactivity patterns prior and after immune suppression.

  2016cites this paper
• Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.

  2015cites this paper
• Differential regulation of IRESs in the Aurora A mRNA by bFGF through the mTOR complex TORC2 modulates Aurora A kinase expression

  2014cites this paper
• Prostate cancer: the need for biomarkers and new therapeutic targets

  2014cites this paper
• Differential regulation of IRESs in the Aurora A mRNA by bFGF through the mTOR complex TORC2 modulates Aurora A kinase expression

  2014cites this paper
• PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance.

  2014cites this paper
• A Combination Strategy to Inhibit Pim‐1: Synergism between Noncompetitive and ATP‐Competitive Inhibitors

  2013cites this paper
• Expressions of osteopontin (OPN), ανβ3 and Pim-1 associated with poor prognosis in non-small cell lung cancer (NSCLC)

  2012cites this paper
• PIM1 kinase as a target for cancer therapy

  2012cites this paper
• Overexpression of Osteopontin, αvβ3 and Pim-1 Associated with Prognostically Important Clinicopathologic Variables in Non-Small Cell Lung Cancer

  2012cites this paper
• Expressions of O steopontin (OPN), α ν β3 and Pim -1 A ssociated with Poor Prognosis in Non- small C ell Lung C ancer (NSCLC)

  2012cites this paper
• PIM 1 kinase as a target for cancer therapy

  2012cites this paper
• Implication de la voie de signalisation Src/Stat3 dans l'étiologie de l'hypertension artérielle pulmonaire

  2011cites this paper
• A pivotal role for Pim-1 kinase in esophageal squamous cell carcinoma involving cell apoptosis induced by reducing Akt phosphorylation.

  2010cites this paper
• Why target PIM1 for cancer diagnosis and treatment?

  2010cites this paper
• p53-Dependent Induction of Prostate Cancer Cell Senescence by the PIM1 Protein Kinase

  2010cites this paper
• Molecular Cancer esearch Cycle , Cell Death , and Senescence-Dependent Induction of Prostate Cancer Cell R escence by the PIM 1 Protein Kinase

  2010cites this paper
• Expression and distribution of cystic fibrosis transmembrane conductance regulator in neurons of the spinal cord

  2009cites this paper